ARCT - Arcturus Therapeutics Holdings Inc.
IEX Last Trade
16.88
0.060 0.355%
Share volume: 6,438
Last Updated: Thu 26 Dec 2024 08:30:15 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.11%
PREVIOUS CLOSE
CHG
CHG%
$16.82
0.06
0.36%
Summary score
24%
Profitability
25%
Dept financing
10%
Liquidity
69%
Performance
15%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-8.93%
Return on assets
-6.39%
Return on sales
-827.88%
Return on invested capital
49.22%
Total debt ratio
35.92%
Debt ratio change over timeo
-0.52%
Current Ratio
5.2%
Quick Ratio
4.7%
Cash Position Ratio
4.84%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
-9.65%
Return on assets
-7.15%
Return on sales
-177.11%
Return on invested capital
63.37%
Total debt ratio
36.18%
Debt ratio change over timeo
-0.2%
Current Ratio
4.18%
Quick Ratio
4.18%
Cash Position Ratio
3.3%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
-10.16%
Return on assets
-7.26%
Return on sales
-80.01%
Return on invested capital
37.06%
Total debt ratio
36.98%
Debt ratio change over time
0.24%
Current Ratio
3.26%
Quick Ratio
3.26%
Cash Position Ratio
2.5%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-119.89%
Return on assets
-113.71%
Return on sales
-1423.2%
Return on invested capital
-13.22%
Total debt ratio
-52.22%
Debt ratio change over time
-0.52%
Current Ratio
6.02%
Quick Ratio
5.24%
Cash Position Ratio
5.39%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | ARCT | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -8.93% | 13.79% | 34.47% | 7.43% |
| Return on assets | -6.39% | 2.76% | 3.15% | 5.62% |
| Return on sales | -827.88% | 28.74% | 32.53% | 40.48% |
| Return on invested capital | 49.22% | 2.36% | 5.39% | 19.77% |
| Profitability | 25% | 41% | 62% | 65% |
| Total debt ratio | 35.92% | 90.46% | 90.54% | 26.74% |
| Debt ratio change over time | -0.52% | 308.97% | -6.99% | 1.18% |
| Dept financing | 10% | 50% | 25% | 7% |
| Current Ratio | 4.18% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 4.18% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 3.3% | 0.36% | 1.28% | 2.93% |
| Liquididy | 75% | 10% | 22% | 52% |
| Short-term ratios | ARCT | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -9.65% | 13.77% | 13.25% | 3.8% |
| Return on assets | -7.15% | 2.43% | 1.89% | 3.09% |
| Return on sales | -177.11% | 24.64% | 23.72% | 30.49% |
| Return on invested capital | 63.37% | 2.14% | 3.39% | 9.18% |
| Profitability | 25% | 66% | 60% | 61% |
| Total debt ratio | 36.18% | 92.14% | 93.05% | 21.79% |
| Debt ratio change over time | -0.2% | 46.38% | -72.08% | 1.51% |
| Dept financing | 10% | 50% | 25% | 7% |
| Current Ratio | 4.18% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 4.18% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 3.3% | 0.36% | 1.28% | 2.93% |
| Liquididy | 67% | 11% | 29% | 72% |